erythromycin has been researched along with Long QT Syndrome in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.33) | 18.7374 |
1990's | 11 (36.67) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 6 (20.00) | 24.3611 |
2020's | 2 (6.67) | 2.80 |
Authors | Studies |
---|---|
Berger, FA; Bunge, JJH; de Groot, NMS; Hunfeld, NGM; van den Bemt, PMLA; van der Sijs, H; van Gelder, T; van Weteringen, W | 1 |
Danhaive, O; Dussart, A; Fobe, C; Moniotte, S; Piersigilli, F; Van Grambezen, B; Vo, C | 1 |
Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Krawczyk, J | 1 |
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M | 1 |
Beck, J; Bode, C; Brunner, M; Franke, G; Hartmann, M; Koren, G; Odening, KE; Perez Feliz, S; Zehender, M; Ziupa, D | 1 |
Chalasani, N; Ghabril, M; Gorski, JC; Hall, SD; Juluri, R; Kim, S; Thong, N; Vuppalanchi, R | 1 |
Bitzer, M; Gregor, M; Riessen, R; Werner, CR | 1 |
Malnick, SD; Melzer, E | 1 |
Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N | 1 |
Hanada, E; Hirota, M; Iga, T; Kotaki, H; Nakaya, H; Ohtani, H; Sato, H; Uemura, N; Yamada, Y | 1 |
Preskorn, SH | 1 |
Duff, HJ; Guo, J; Lees-Miller, JP; Teng, G; Zhan, S | 1 |
Beckmann, BM; Hinterseer, M; Irlbeck, M; Kaab, S; Ney, L; Pfeufer, A; Steinbeck, G | 1 |
Itoh, M; Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H | 1 |
Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H | 1 |
Abernethy, DP; Allareddy, RR; Dettmer, MM; Dikshteyn, M; Jeyaraj, D; Kaufman, ES; Lewis, SA; Meredith, DM; Natarajan, RN; Patel, K | 1 |
Roden, DM | 1 |
Barold, SS; Brandriss, MW; Richardson, WS | 1 |
Pressler, ML; Pride, HP; Rubart, M; Zipes, DP | 1 |
Chang, MS; Chen, SA; Chiang, CE; Hsieh, MH; Lee, SH; Tai, CT; Wen, ZC | 1 |
Antzelevitch, C; Sun, ZQ; Yan, GX; Zhang, ZQ | 1 |
Crijns, HJ; Panhuyzen-Goedkoop, NM | 1 |
Vogt, AW; Zollo, RA | 1 |
Dennis, DM; Guyton, TS; Martynyuk, AE; Morey, TE; Napolitano, CA; Raatikainen, MJ | 1 |
Pasco, J | 1 |
Ferguson, M; Jordan, L; Kent, S; Trotta, R | 1 |
Cox, BF; Gintant, GA; Limberis, JT; McDermott, JS; Wegner, CD | 1 |
Azaz-Livshits, T; Ben-Yehuda, A; Goldschmidt, N; Muszkat, M; Nir-Paz, R | 1 |
Lemery, R; Nattel, S; Ranger, S; Roy, D; Talajic, M | 1 |
Anderson, KP; Freedman, RA; Green, LS; Mason, JW | 1 |
2 review(s) available for erythromycin and Long QT Syndrome
Article | Year |
---|---|
Torsade de pointes.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Dogs; Electrocardiography; Erythromycin; Heart Rate; Histamine Antagonists; Humans; Long QT Syndrome; Torsades de Pointes | 1993 |
Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
Topics: Adult; Erythromycin; Female; Humans; Long QT Syndrome; Pneumonia; Torsades de Pointes | 1994 |
28 other study(ies) available for erythromycin and Long QT Syndrome
Article | Year |
---|---|
Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patients.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Electrocardiography; Erythromycin; Female; Humans; Intensive Care Units; Long QT Syndrome; Male; Middle Aged; Prospective Studies; Risk Factors; Time Factors | 2021 |
Torsade de pointe due to QT prolongation following erythromycin administration in a preterm infant.
Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Infant, Newborn; Infant, Premature; Long QT Syndrome; Pregnancy; Tachycardia; Torsades de Pointes; Ureaplasma Infections | 2022 |
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Dantrolene; Disease Models, Animal; Electrocardiography; Erythromycin; Heart Rate; Heart Ventricles; Isolated Heart Preparation; Long QT Syndrome; Rabbits; Ryanodine Receptor Calcium Release Channel; Time Factors; Torsades de Pointes; Veratridine | 2018 |
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation | 2018 |
Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits.
Topics: Action Potentials; Animals; Animals, Genetically Modified; Erythromycin; Female; Heart; Long QT Syndrome; Piperidines; Pyridines; Rabbits | 2014 |
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Topics: Administration, Oral; Anti-Bacterial Agents; Cytochrome P-450 CYP3A; Electrocardiography; Erythromycin; Humans; Intestinal Mucosa; Liver Cirrhosis; Long QT Syndrome; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors | 2011 |
[Unexpected complication following esophageal variceal hemorrhage - Case 2/2011].
Topics: Amiodarone; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Electric Countershock; Electrocardiography, Ambulatory; Erythromycin; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Liver Cirrhosis, Alcoholic; Long QT Syndrome; Male; Middle Aged; Peptide Fragments; Recurrence; Risk Factors; Tachycardia; Torsades de Pointes | 2011 |
Compromise of patient safety in research report.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Liver Cirrhosis; Long QT Syndrome; Portasystemic Shunt, Transjugular Intrahepatic | 2012 |
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes | 2002 |
Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Delayed Rectifier Potassium Channels; Disopyramide; Dose-Response Relationship, Drug; Erythromycin; In Vitro Techniques; Long QT Syndrome; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley | 2003 |
Drug-drug interactions: proof of relevance (part I).
Topics: Anti-Bacterial Agents; Antifungal Agents; Antipsychotic Agents; Cyclophilins; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Humans; Long QT Syndrome; Mental Disorders; Metronidazole | 2005 |
Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C.
Topics: Action Potentials; Animals; Body Temperature; Cation Transport Proteins; Disease Susceptibility; Electrophysiology; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Gene Expression Regulation, Neoplastic; Long QT Syndrome; Mice; Myocytes, Cardiac; Time Factors | 2005 |
Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Echocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Female; Fluconazole; Humans; Hypokalemia; Long QT Syndrome; Mutation; Recurrence; Respiratory Distress Syndrome; Torsades de Pointes; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin.
Topics: Action Potentials; Animals; Cell Line; Cisapride; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Gastrointestinal Agents; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Potassium Channel Blockers; Rabbits; Risk Assessment; Time Factors; Torsades de Pointes; Transfection | 2007 |
Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
Topics: Action Potentials; Anesthesia, General; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cisapride; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Halothane; Heart Rate; Infusions, Intravenous; Long QT Syndrome; Male; Models, Animal; Risk Assessment; Time Factors; Torsades de Pointes; Ventricular Function, Left; Ventricular Pressure | 2007 |
I(Kr) channel blockade to unmask occult congenital long QT syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Case-Control Studies; Erythromycin; Female; Humans; Long QT Syndrome; Male; Mutation; Phenotype; Potassium Channel Blockers; Potassium Channels; Propranolol | 2008 |
Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.
Topics: Action Potentials; Animals; Dogs; Electrocardiography; Erythromycin; In Vitro Techniques; Long QT Syndrome; Papillary Muscles; Potassium Channels; Purkinje Fibers; Sodium Channels | 1993 |
Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Astemizole; Cardiac Pacing, Artificial; Electrocardiography; Erythromycin; Female; Histamine H1 Antagonists; Humans; Long QT Syndrome; Propranolol; Rhinitis; Torsades de Pointes | 1996 |
Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
Topics: Action Potentials; Animals; Anti-Bacterial Agents; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Endocardium; Erythromycin; Heart; Heart Ventricles; In Vitro Techniques; Long QT Syndrome; Male; Microelectrodes; Myocardium; Patch-Clamp Techniques; Pericardium; Potassium Channels; Torsades de Pointes | 1996 |
[Iatrogenic collapse; can this be prevented?].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Disopyramide; Erythromycin; Female; Humans; Long QT Syndrome; Male; Middle Aged; Sotalol; Syncope | 1997 |
Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Erythromycin; Female; Humans; Jejunoileal Bypass; Long QT Syndrome; Preoperative Care; Torsades de Pointes | 1997 |
Ionic basis of the differential effects of intravenous anesthetics on erythromycin-induced prolongation of ventricular repolarization in the guinea pig heart.
Topics: Action Potentials; Anesthetics, Intravenous; Animals; Erythromycin; Female; Guinea Pigs; Heart; Heart Ventricles; Long QT Syndrome; Male; Potassium Channels | 1997 |
What has the patient been taking?
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlorothiazide; Cimetidine; Diagnosis, Differential; Diuretics; Electrocardiography; Electrolytes; Erythromycin; Female; Histamine H1 Antagonists; Humans; Long QT Syndrome; Sodium Chloride Symporter Inhibitors; Terfenadine; Torsades de Pointes | 1998 |
T wave alternans associated with HIV cardiomyopathy, erythromycin therapy, and electrolyte disturbances.
Topics: Adult; Cardiomyopathies; Electrocardiography; Erythromycin; HIV Infections; Humans; Long QT Syndrome; Male; Water-Electrolyte Imbalance | 1998 |
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
Topics: Action Potentials; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cisapride; Dogs; Erythromycin; Female; Fluoroquinolones; Imidazoles; In Vitro Techniques; Indoles; Long QT Syndrome; Male; Models, Biological; Moxifloxacin; Perfusion; Piperazines; Purkinje Fibers; Quinolines; Sotalol; Swine; Torsades de Pointes | 2001 |
Compound cardiac toxicity of oral erythromycin and verapamil.
Topics: Aged; Anti-Bacterial Agents; Blood Cell Count; Calcium Channel Blockers; Electrocardiography; Erythromycin; Female; Heart Block; Humans; Long QT Syndrome; Verapamil | 2001 |
Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.
Topics: Action Potentials; Aged; Animals; Arrhythmias, Cardiac; Dogs; Electrocardiography; Erythromycin; Humans; In Vitro Techniques; Long QT Syndrome; Male; Purkinje Fibers; Quinidine; Tachycardia | 1990 |
Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome.
Topics: Adult; Arrhythmias, Cardiac; Cough; Erythromycin; Heart Ventricles; Humans; Long QT Syndrome; Male | 1987 |